Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated...
Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
ObjectivesAssessing influence of anti-adalimumab (ADA) antibodies (AAA) on serum trough ADA levels and uveitis activity in long-term ADA treatment of juvenile idiopathic arthritis (JIA)-associated uveitis.Patients and interventionsThis prospective observational study included 20 patients from a single centre treated with ADA for active uveitis refr...
Alternative Titles
Full title
Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2073320163
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2073320163
Other Identifiers
ISSN
0003-9888
E-ISSN
1468-2044
DOI
10.1136/archdischild-2018-315060
